6-APB 130 mg pellets
6-APB 130 mg pellets Prisklasse: €5.95 til €737.50
Tilbake til produktene
1V-LSD Valerie 225mcg
1V-LSD Valerie 225mcg Prisklasse: €10.00 til €369.00
aMT - Bilde 1
aMT - Bilde 2
aMT - Bilde 3

aMT

aMT-egenskaper

Synonym: alfa-metyltryptamin
CAS-nummer: 299-26-3
Formel: C11H14N2
Molar masse: 174,247 g mol−1
Renhet: >98%

Prisklasse: €34.95 til €499.95

Legg til for å sammenligne
Legg til i ønskelisten
SPAR 15%

mer 2 produkter

SPAR 50%

6 for prisen av 3

* Informasjonen på denne siden er et sammendrag og er ikke ment å dekke all tilgjengelig informasjon om dette legemidlet. Den dekker ikke alle mulige bruksområder, bruksanvisninger, forholdsregler, legemiddelinteraksjoner eller bivirkninger, og erstatter ikke helsepersonellets ekspertise og vurdering.

AMT (Alpha-Methyltryptamine) – Scientific Product Description

General Information

Substance Name:  Alfa-metyltryptamin (AMT)
Chemical Class:  Tryptamine derivative
Status:  Research chemical
Dosage:  Varies (10-50mg for research purposes)
Form:  Powder or pellets (depending on availability)

Farmakologiske egenskaper

AMT is a monoamine alkaloid with a unique mechanism of action that both:

  • Serotonergic  (5-HT₂A agonism)

  • Dopaminergic  (dopamine reuptake inhibition)

  • Exhibits noradrenergic  effects

Potential Research Areas

1. Neuropsychological Examination

  • Influence on perceptual processing

  • Modulation of cognitive flexibility

  • Effects on creative thinking

2. Behavioral Science Studies

  • Social interaction patterns

  • Emotional processing mechanisms

  • Motivation and reward systems

3. Theoretical Applications

  • Possible antidepressant effects (preclinical study)

  • Impact on sleep architecture

  • Neuroplastic changes

Dosage & Protocol

Research dose range:

  • Lav dose:  10–20 mg

  • Gjennomsnittlig dose:  20–35 mg

  • Høy dose:  35–50 mg

Time lapse:

  • Onset of effects: 45-90 minutes

  • Peak performance: 3-5 hours

  • Total duration: 8-12 hours

Safety aspects

Bivirkninger

  • Increased body temperature

  • Tachycardia

  • Mydriasis

  • Possible gastrointestinal discomfort

Contraindications

  • Combination with MAO inhibitors

  • Cardiovascular diseases

  • Psychiatric history

Laboratory analysis

Renhet:  ≥97% (HPLC)
Stability:  Store in a cool, dry place (<25°C)
Impurities:  <0.5% (GC-MS analysis)

Juridisk status

Netherlands:  Opium Act Schedule I
Belgium:  Prohibited substance
EU:  Under EU NPS legislation

Research protocols

  1. Start low:  10mg initial test dose

  2. Pharmaceutical monitoring:  Blood pressure and temperature measurement

  3. Intervals:  Minimum 7 days between experiments

Important Warnings

❌ Ikke konsumert
❌ Do not combine with other psychoactives
❌ Avoid prolonged or frequent use

This product is intended solely for in vitro research og scientific study under controlled laboratory conditions.

1cP-LSD 150 MCG Kunstpapir O-DSMT 50 mg pellets 1V-LSD 150 MCG Blottere 6-CL-ADBA